Arrayjet

Arrayjet is a leading company in the biotechnology industry, specializing in microarray solutions. With its innovative inkjet technology and a focus on unmatched service excellence, the company has established a strong brand presence and garnered a respected reputation in the sector. Founded in 2000 with backing from Archangel Investors Ltd and the Scottish Government, Arrayjet developed and patented an inkjet technology for printing biological samples onto solid substrates, creating screening tools known as microarrays. Since commercializing its technology in 2006, Arrayjet has maintained a leadership position in the industry, serving a diverse customer base across 27 countries.

Initially focused on instruments, Arrayjet expanded its offerings to include contract services in 2010. Subsequently, in 2011, the company launched Arrayjet AdvanceTM to provide outsourced services in assay development, printing, and contract manufacturing. Later, in 2016, Arrayjet introduced Arrayjet ExpertiseTM to offer consultancy, project management, and training services, further enhancing its portfolio of offerings in the market.

The company's most recent £650.00KVenture Round investment at 07 September 2016 was secured from Archangel Investors Limited, highlighting the continued confidence and support from its existing investors.

Overall, Arrayjet's commitment to innovation, strong customer base, and diverse service offerings position the company as a notable entity in the biotechnology sector, with potential for continued growth and success in the future.